Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on Diagnosis

March 16, 2020 updated by: Haotian Lin, Sun Yat-sen University

Artificial Intelligence System for Assessing Image Quality of Slit-Lamp Images and Its Effects on Diagnosis: A Clinical Trial

Slit-lamp images are widely used in ophthalmology for the detection of cataract, keratopathy and other anterior segment disorders. In real-world practice, the quality of slit-lamp images can be unacceptable, which can undermine diagnostic accuracy and efficiency. Here, the researchers established and validated an artificial intelligence system to achieve automatic quality assessment of slit-lamp images upon capture. This system can also provide guidance to photographers according to the reasons for low quality.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510060
        • Zhongshan Ophthalmic Center, Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Inclusion Criteria: - Patients should be aware of the contents and signed for the informed consent. Exclusion Criteria: - 1. Patients who cannot cooperate with a photographer such as some paralytics, the patients with dementia and severe psychopaths. - 2. Patients who do not agree to sign informed consent

Description

Inclusion Criteria:

  • Patients should be aware of the contents and signed for the informed consent.

Exclusion Criteria:

  • 1. Patients who cannot cooperate with a photographer such as some paralytics, the patients with dementia and severe psychopaths.
  • 2. Patients who do not agree to sign informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Slit-lamp image quality assessment
Device: an artificial intelligence system for quality assessment of slit-lamp images. These patients are enrolled in primary healthcare units or the AI clinic at Zhongshan Ophthalmic Center
The participant only needs to take several slit-lamp images as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance of artificial intelligence system for distinguish between good image quality and poor image quality
Time Frame: 3 months
Area under the receiver operating characteristic curves, sensitivity, specificity, positive and negative predictive values,accuracy
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The comparison of the performance for previous artificial intelligence diagnostic system with slit-lamp images of different image quality
Time Frame: 3 months
Cohen's kappa coefficient, P value and other related statistic results
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Anticipated)

July 1, 2020

Study Completion (Anticipated)

July 1, 2020

Study Registration Dates

First Submitted

March 16, 2020

First Submitted That Met QC Criteria

March 16, 2020

First Posted (Actual)

March 19, 2020

Study Record Updates

Last Update Posted (Actual)

March 19, 2020

Last Update Submitted That Met QC Criteria

March 16, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IMAQUA2020-China-02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on Taking slit-lamp images

3
Subscribe